HENRY JEMIL ESBER

CIK 1391501 · EVP Pre-Clinical Business Dev. · last filed 2019-07-03

HENRY JEMIL ESBER is an EVP Pre-Clinical Business Dev. who has filed 39 SEC Form 4 insider transactions across 3 companies since 2007. Current disclosed insider exposure totals $520.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$520.7K

Companies

3

Total Filings

39

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SEELOS THERAPEUTICS, INC. (APRI) Delisted	Director	35,492	—	—	$0	4	2012-01-04
NEXM	EVP Pre-Clinical Business Dev.	220,656	$2.36	$520.7K	$0	3	2010-04-13
GALECTIN THERAPEUTICS INC (PRW) Delisted	Director	—	—	—	$0	2	2008-03-17

Recent Filings

39 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $
2019-07-03	—	Grant (A)	—	$0
2019-04-02	—	Grant (A)	—	$0
2019-01-04	—	Grant (A)	—	$0
2018-10-02	—	Grant (A)	—	$0
2018-07-19	—	Grant (A)	—	$0
2018-04-03	—	Grant (A)	—	$0
2018-02-27	—	Grant (A)	—	$0
2017-11-27	—	Buy (P)	+100,000	$9.3K
2017-10-02	—	Grant (A)	—	$0
2017-07-03	—	Grant (A)	—	$0

Showing 1–10 of 39

Page 1 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.